🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
RATIONALE: Azadirachta indica may be an effective treatment for chronic lym...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01251250
RATIONALE: Drugs used in chemotherapy, such as fludarabine phosphate, work ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00845104
RATIONALE: Giving chemotherapy, such as fludarabine phosphate, busulfan, an...
Status
Completed
Location
HealthOne Presbyterian St. Lukes Medical Center
Start Date
2006-01
Trial ID
NCT00322101
Treatments Being Tested
RATIONALE: Pentostatin may stop the growth of cancer cells by blocking some...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2005-07
Trial ID
NCT00546377
This clinical trial is studying biomarkers as a diagnostic tool in samples ...
Status
Completed
Location
Children's Oncology Group
Start Date
2012-02
Trial ID
NCT01540578
Treatments Being Tested
RATIONALE: Studying samples of tissue from patients with cancer in the labo...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01057199
The main aim of this study is to evaluate the effectiveness of the clinical...
Status
Terminated
Location
Boris V Afanasyev, MD, Prof.
Start Date
2020-01-15
Trial ID
NCT04242121
Treatments Being Tested
RATIONALE: Bexarotene may help cancer or abnormal cells become more like no...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2006-11
Trial ID
NCT00425477
RATIONALE: Immunotoxins, such as RFT5-dgA immunotoxin (also called anti-CD2...
Status
Terminated
Location
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Start Date
2008-11-07
Trial ID
NCT00667017
Treatments Being Tested